Welcome to the third issue of Focus on China Compliance for 2015. According to the FCPA Blog’s October 2015 Corporate Investigations List, China leads the countries reported to be involved in FCPA investigations with 29...more
10/29/2015
/ Aiding and Abetting ,
Air Pollution ,
Anti-Bribery ,
Anti-Corruption ,
Bribery ,
China ,
Compliance ,
Conflicts of Interest ,
Contaminated Properties ,
Cooperation ,
Corruption ,
Criminal Conspiracy ,
Criminal Prosecution ,
Data Privacy ,
Data Security ,
Death Penalty ,
Department of Justice (DOJ) ,
Embezzlement ,
Employee Privacy Rights ,
Enforcement Actions ,
Environmental Policies ,
Explosions ,
Extradition ,
Financing ,
Fines ,
Foreign Corrupt Practices Act (FCPA) ,
Hazardous Waste ,
Individual Accountability ,
Internal Controls ,
Internal Investigations ,
Joint Tortfeasors ,
Joint Venture ,
Law Enforcement ,
Multinationals ,
New Legislation ,
Permits ,
Personal Data ,
Professional Misconduct ,
Remediation ,
Risk Mitigation ,
Safety Inspections ,
Search & Seizure ,
Securities and Exchange Commission (SEC) ,
Sentencing ,
Surveillance ,
Third-Party ,
Toxic Chemicals ,
Whistleblowers ,
White Collar Crimes
Recently, the co-founders of a firm primarily engaged in investigation-related services were arrested in Shanghai. The arrest indicates protected information laws are being rigorously enforced in China, and could signal a...more
The Chinese Government’s wide-ranging bribery and corruption investigation into the pharmaceutical industry takes a new turn every week. Media reports contain numerous incidents of purported whistleblowers making allegations...more
The Chinese government’s recent crackdown on alleged bribery and corruption of local officials by multinational pharmaceutical companies could signal a broad trend toward elevated scrutiny of all foreign corporations...more